The daily reality for a post-acute care administrator often involves navigating a deluge of fragmented patient data from hospital EMRs, faxes, and referral portals, all while a ticking clock pressures them to make a high-stakes decision on admission. This single, critical choice—whether a facility c
I'm joined today by Faisal Zain, a leading expert in U.S. healthcare policy with deep insights into hospital finance and pharmaceutical pricing. We're here to unpack the recent, and for many, welcome decision by the Department of Health and Human Services to scrap its controversial 340B
A New Dawn for Discretion in Men's Health The landscape of erectile dysfunction (ED) treatment has remained relatively unchanged for decades, dominated by oral tablets that have become household names. However, the recent FDA approval of Vybrique, the first and only oral dissolving film
For decades, the intricate and often bewildering system of prescription drug pricing in the United States has been orchestrated by powerful but little-understood intermediaries whose operations remained largely shielded from public and regulatory view. These entities, known as Pharmacy Benefit
The labyrinthine process of prior authorization, a persistent source of administrative friction and delays in patient care, is now at the center of a technological revolution driven by artificial intelligence. The adoption of AI represents a significant advancement in the healthcare administration
For years, healthcare organizations have diligently tracked, reported, and scrutinized a single, seemingly definitive number to gauge the success of their drug diversion prevention programs: the count of confirmed cases. This figure, often low, has been a source of reassurance for leadership and a
